The present invention relates to substituted diphenyl heterocycle compounds
and pharmaceutical compositions thereof that inhibit replication of HCV
virus. The present invention also relates to the use of the compounds
and/or compositions to inhibit HCV replication and/or proliferation and to
treat or prevent HCV infections.
